References
- Anuchapreeda, S., Leechanachai, P., Smith, M.M., Ambudkar, S.V., Limtrakul, P. 2002. Modulation of p-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem. Pharmacol. 64, 573-582. https://doi.org/10.1016/S0006-2952(02)01224-8
- Choi, B.H., Kim, C.G., Lim, Y. Shin, S.Y. and Lee, Y.H., 2008. Curcumin downregulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NFeB pathway. Cancer Letters 259, 111-118. https://doi.org/10.1016/j.canlet.2007.10.003
- Chavanpatil, M.D., Patil Y., Panyam, J. 2006. Susceptibility of nanoparticles-encapsulated paclitaxel to p-glycoprotein-mediated drug efflux. Int. J. Pharm. 320, 150-156. https://doi.org/10.1016/j.ijpharm.2006.03.045
- Chi, K.N., Chia, S.K., Dixon, R., Newman, M.J., Wacher, V.J., Sikic, B., Gelmon, K.A., 2005. A phase I pharmacokinetic study of the P-glycoprotein inhibitor, ONT-093, in combination with paclitaxel in patients with advanced cancer. Invest. New Drugs 23, 311-315. https://doi.org/10.1007/s10637-005-1439-x
- Choi, B.H., Kim, C.G., Lim, Y., Shin, S.Y., Lee, Y.H., 2008. Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway. Cancer Lett. 259(1), 111-118. https://doi.org/10.1016/j.canlet.2007.10.003
- Ganta, S., Amiji, M., 2009. Coadministration of paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells. Mol. Pharm. 6(3), 928-939. https://doi.org/10.1021/mp800240j
- Germano, S., O'Driscoll, L., 2009. Breast cancer: understanding sensitivity and resistance to chemotherapy and targeted therapies to aid in personalized medicine. Curr. Cancer Drug Targets 9(3), 393-418.
- Gottesman, M.M., 2002. Mechanisms of cancer drug resistance. Annu. Rev. Med. 53, 615-627. https://doi.org/10.1146/annurev.med.53.082901.103929
- Labbozzetta, M., Notarbartolo, M., Poma, P., Maurici, A., Inguglia, L., Marchetti, P., Rizzi, M., Baruchello, R., Simoni, D., D'Alessandro, N. 2009. Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer. Ann. N. Y. Acad. Sci. 1155, 278-283. https://doi.org/10.1111/j.1749-6632.2009.03699.x
- Lee, E.S., Na, K. and Bae, Y.H. 2005. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. J. Control. Release 103, 405-418. https://doi.org/10.1016/j.jconrel.2004.12.018
- Longley, D.B., Johnston, P.G., Wilson, M., Mc Ewan, M., Allen, W.L., Mc Dermot, U., Galligan, L., Johnston,P.G. 2005. Molecular mechanisms of drug resistance. J. Phathol. 205, 275-292. https://doi.org/10.1002/path.1706
- Marbeuf-Gueye, C., Salerno, M., Quidu, P., Garnier-Suillerot, A.,2000. Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P. Eur. J. Pharmacol. 391(3), 207-216. https://doi.org/10.1016/S0014-2999(00)00047-9
- Molnár, J., Engi, H., Hohmann, J., Molnar, P., Deli, J., Wesolowska, O., Michalak, K., Wang, Q. 2010. Reveresal of multidrug resistance by natural substances from plants. Curr. Top. Med. Chem. 10(17), 1757-1768. https://doi.org/10.2174/156802610792928103
- Qureshi, S., Shah, A.H., Ageel, A.M. 1992. Toxicity studies on Alpinia galangal and Curcuma longa. Planta Med. 58, 124-7. https://doi.org/10.1055/s-2006-961412
- Shapira, A., Livney, Y.D., Broxterman, H.J., Assaraf, Y.G. 2011. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance. Drug Resist Updat 14(3), 150-63. https://doi.org/10.1016/j.drup.2011.01.003
- Szakacs, G., Paterson, J.K., Ludwig, J.A., Booth-Genthe, C. and Gottesman, M.M. 2006. Targeting multidrug resistance in cancer. Nature Rev. 5, 219-234. https://doi.org/10.1038/nrd1984
- Toppmeyer, D., Seidman, A.D., Pollak, M., Russell, C., Tkaczuk, K., Verma, S., Overmoyer, B., Garg, V., Ette, E., Hardu, M.W., Demetri, G.D. 2002. Safety and efficacy of the multidrug resistance inhibitor in combination with paclitaxel in advanced breast cancer refractory to paclitaxel, Clin. Cancer Res. 8, 670- 678.
- Tsukamoto, F., Shiba, E., Taguchi, T., Sugimoto, T., Watanabe, T., Kim, S.J., Tanji, Y., Kimoto, K., Izukura, M., Takai, S.I. 1997. Immunochemical detection of P-glycoprotein in breast cancer abd its significance as a prognostic factor. Breast Cancer. 25, 259-263.